GlassScriptPhysician profile
Cynthia Tracy
NPI 1780754010
$2,701.55
in general payments reported to CMS, 2019-2025
24 companies · $422 in 2025
The $422 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $198 · 2021: $239 · 2022: $511 · 2023: $401 · 2024: $526 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $879.23 | 2021-2024 | Cobalt Dr Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $363.62 | 2023-2025 | Aveir, Assurity, Jot Dx |
| Boston Scientific Corporation | $282.11 | 2019-2025 | Farapulse, Watchman Access System, Wolverine Coronary Cutting Balloon |
| Medtronic Vascular, INC. | $246.49 | 2019-2020 | |
| Edwards Lifesciences Corporation | $234.17 | 2019-2025 | Sapien 3 Ultra Resilia |
| Cook Medical LLC | $127.36 | 2020-2025 | Rosen, Cook Celect, Torcon Nb |
| Angiodynamics, INC. | $73.01 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71.54 | 2023-2025 | Lifevest |
| Becton, Dickinson and Company | $51.06 | 2020-2024 | Provena Midline |
| Recor Medical INC | $45.92 | 2025 | Paradise Ultrasound Renal Denervation System |
| Inari Medical, INC. | $41.85 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| W. L. Gore & Associates, INC. | $36.97 | 2020-2023 | Gore Excluder Aaa Endoprosthesis |
| Novo Nordisk INC | $33.99 | 2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.97 | 2024 | Jardiance |
| Cardiovascular Systems INC. | $26.94 | 2019-2023 | Diamondback Coronary |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $23.60 | 2025 | Repatha |
| Stryker Corporation | $22.18 | 2025 | Flowtriever |
| Teleflex LLC | $22.13 | 2023 | Trapliner |
| Bard Peripheral Vascular, INC. | $19.79 | 2021 | |
| Shockwave Medical, INC | $18.23 | 2019 | |
| Bard Access Systems, INC. | $14.49 | 2019 | |
| Pfizer INC. | $14.29 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $13.61 | 2024 | Camzyos |
| Novartis Pharmaceuticals Corporation | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Tracy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.